跳至主要内容
临床试验/ACTRN12622000050752
ACTRN12622000050752尚未招募未知

The Effect of Exercise Prescription and Delivery in Congenital Heart Disease – The Congenital Heart Fitness Intervention Trial: CH-FIT

niversity of Sydney0 个研究点目标入组 370 人开始时间: 2022年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
370

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
10 Years 至 55 Years(—)
性别
All

入选标准

  • Aged 10 to 55 years
  • -People with congenital heart disease of moderate or great complexity
  • -At least 6 months post surgical repair
  • -Medically stable and on stable therapy for at least 3 months

排除标准

  • -Physiological stage D
  • -Planned intervention within 2 years
  • -Mental or physical disability that prevents participation in exercise training
  • -Current or actively planned pregnancy within one year
  • -Uncontrolled (systemic) hypertension at rest of exercise
  • -Clinically unstable or recent major change in therapy within 3 months
  • -COVID-19 unvaccinated people despite being eligible according to ATAGI
  • -People with unreliable internet connection
  • -People currently participating in more than 30 minutes of sports or exercise training three times a week

研究者

相似试验

The Effect of Exercise Prescription and Delivery in... | 临床试验